Pfizer/BioNTech COVID-19 vaccine effectiveness drops after 6 months, study shows

By Manas Mishra

Oct 4 (Reuters) – The effectiveness of the Pfizer Inc (PFE.N)/BioNTech SE vaccine in preventing infection by the coronavirus dropped to 47% from 88% six months after the second dose, according to data published on Monday that U.S. health agencies considered when deciding on the need for booster shots.

The data, which was published in the Lancet medical journal, had been previously released in August ahead of peer review.

The analysis showed that the vaccine’s effectiveness in preventing hospitalization and death remained high at 90% for at least six months, even against the highly contagious Delta variant of the coronavirus.

Read Full Article Here

Share on facebook
Facebook
Share on twitter
Twitter
Share on linkedin
LinkedIn
Share on reddit
Reddit
Share on telegram
Telegram
Share on whatsapp
WhatsApp
Share on email
Email

Related Stories

Business Spotlight

RDA Business Directory Spotlight

Melbourne Decking & Landscaping RDA Business Directory Spotlight– Melbourne Decking & Landscaping | https://www.reignitedemocracyaustralia.com.au/places/melbourne-decking-and-landscaping/ RDA now has 499+ listings on our Business Directory, an easy

Read More »
Latest News

Support Reclaim the Line

Support Reclaim the Line | ttps://consciousclothing.shop/products/reclaimtheline-free-the-nation-t-shirt-mens-womens-white Reclaim The Line is gearing up for major events all across the country again this weekend. If you’re looking

Read More »

Responses